{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["13(10)"],"submitter":["Barh D"],"pubmed_abstract":["Recently, two cases of complete remission of classical Hodgkin lymphoma (cHL) and follicular lymphoma (FL) after SARS-CoV-2 infection were reported. However, the precise molecular mechanism of this rare event is yet to be understood. Here, we hypothesize a potential anti-tumor immune response of SARS-CoV-2 and based on a computational approach show that: (i) SARS-CoV-2 Spike-RBD may bind to the extracellular domains of CD15, CD27, CD45, and CD152 receptors of cHL or FL and may directly inhibit cell proliferation. (ii) Alternately, upon internalization after binding to these CD molecules, the SARS-CoV-2 membrane (M) protein and ORF3a may bind to gamma-tubulin complex component 3 (GCP3) at its tubulin gamma-1 chain (TUBG1) binding site. (iii) The M protein may also interact with TUBG1, block"],"journal":["Viruses"],"pagination":["1927"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8539762"],"repository":["biostudies-literature"],"pubmed_title":["Potential Molecular Mechanisms of Rare Anti-Tumor Immune Response by SARS-CoV-2 in Isolated Cases of Lymphomas."],"pmcid":["PMC8539762"],"pubmed_authors":["Aljabali AAA","Azevedo V","Uversky VN","Tiwari S","Alsharif KF","Soares SC","Takayama K","Weener ME","Silva Andrade B","Tambuwala MM","Barh D","Gabriel Rodrigues Gomes L","Alzahrani KJ","Lundstrom K","Ghosh P","Serrano-Aroca A","Hassan SS","Redwan EM"],"additional_accession":[]},"is_claimable":false,"name":"Potential Molecular Mechanisms of Rare Anti-Tumor Immune Response by SARS-CoV-2 in Isolated Cases of Lymphomas.","description":"Recently, two cases of complete remission of classical Hodgkin lymphoma (cHL) and follicular lymphoma (FL) after SARS-CoV-2 infection were reported. However, the precise molecular mechanism of this rare event is yet to be understood. Here, we hypothesize a potential anti-tumor immune response of SARS-CoV-2 and based on a computational approach show that: (i) SARS-CoV-2 Spike-RBD may bind to the extracellular domains of CD15, CD27, CD45, and CD152 receptors of cHL or FL and may directly inhibit cell proliferation. (ii) Alternately, upon internalization after binding to these CD molecules, the SARS-CoV-2 membrane (M) protein and ORF3a may bind to gamma-tubulin complex component 3 (GCP3) at its tubulin gamma-1 chain (TUBG1) binding site. (iii) The M protein may also interact with TUBG1, block","dates":{"release":"2021-01-01T00:00:00Z","publication":"2021 Sep","modification":"2026-04-08T07:49:28.239Z","creation":"2024-11-15T05:41:51.656Z"},"accession":"S-EPMC8539762","cross_references":{"pubmed":["34696358"],"doi":["10.3390/v13101927"]}}